Literature DB >> 15054110

EphA2 receptor tyrosine kinase regulates endothelial cell migration and vascular assembly through phosphoinositide 3-kinase-mediated Rac1 GTPase activation.

Dana M Brantley-Sieders1, Justin Caughron, Donna Hicks, Ambra Pozzi, Joseph C Ruiz, Jin Chen.   

Abstract

Angiogenesis is critical for vascular remodeling during development and contributes to the pathogenesis of diseases such as cancer. Targeted disruption of several EphB class receptor tyrosine kinases results in vascular remodeling defects during embryogenesis. The role of EphA class receptors in vascular remodeling, however, is not well-characterized. We recently demonstrated that global inhibition of EphA receptors disrupts endothelial migration induced by ephrin, VEGF or tumor-derived signals, though the specific target remained undefined. Here, we report that EphA2 regulates endothelial cell assembly and migration through phosphoinositide (PI) 3-kinase-mediated activation of Rac1 GTPase in two model systems: primary bovine and murine pulmonary microvascular endothelial cells. EphA2-deficient endothelial cells fail to undergo vascular assembly and migration in response to ephrin-A1 in vitro. Ephrin-A1 stimulation induces PI3-kinase-dependent activation of Rac1 in wild-type endothelial cells, whereas EphA2-deficient cells fail to activate Rac1 upon stimulation. Expression of dominant negative PI3-kinase or Rac1 inhibits ephrin-A1-induced endothelial cell migration. Consistent with in vitro data, EphA2-deficient mice show a diminished angiogenic response to ephrin-A1 in vivo. Moreover, EphA2-deficient endothelial cells fail to assemble in vivo when transplanted into recipient mice. These data suggest that EphA2 is an essential regulator of post-natal angiogenesis.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15054110     DOI: 10.1242/jcs.01061

Source DB:  PubMed          Journal:  J Cell Sci        ISSN: 0021-9533            Impact factor:   5.285


  90 in total

1.  A role for epha2 in cell migration and refractive organization of the ocular lens.

Authors:  Yanrong Shi; Alicia De Maria; Thomas Bennett; Alan Shiels; Steven Bassnett
Journal:  Invest Ophthalmol Vis Sci       Date:  2012-02-01       Impact factor: 4.799

2.  Biomimetic hydrogels with immobilized ephrinA1 for therapeutic angiogenesis.

Authors:  Jennifer E Saik; Daniel J Gould; Aakash H Keswani; Mary E Dickinson; Jennifer L West
Journal:  Biomacromolecules       Date:  2011-06-15       Impact factor: 6.988

3.  Kaposi's sarcoma-associated herpesvirus interacts with EphrinA2 receptor to amplify signaling essential for productive infection.

Authors:  Sayan Chakraborty; Mohanan Valiya Veettil; Virginie Bottero; Bala Chandran
Journal:  Proc Natl Acad Sci U S A       Date:  2012-04-16       Impact factor: 11.205

4.  The ephrin receptor tyrosine kinase A2 is a cellular receptor for Kaposi's sarcoma–associated herpesvirus.

Authors:  Alexander S Hahn; Johanna K Kaufmann; Effi Wies; Elisabeth Naschberger; Julia Panteleev-Ivlev; Katharina Schmidt; Angela Holzer; Martin Schmidt; Jin Chen; Simone König; Armin Ensser; Jinjong Myoung; Norbert H Brockmeyer; Michael Stürzl; Bernhard Fleckenstein; Frank Neipel
Journal:  Nat Med       Date:  2012-06       Impact factor: 53.440

Review 5.  Eph/ephrin molecules--a hub for signaling and endocytosis.

Authors:  Mara E Pitulescu; Ralf H Adams
Journal:  Genes Dev       Date:  2010-11-15       Impact factor: 11.361

6.  EphB2 and EphB4 receptors forward signaling promotes SDF-1-induced endothelial cell chemotaxis and branching remodeling.

Authors:  Ombretta Salvucci; Maria de la Luz Sierra; Jose A Martina; Peter J McCormick; Giovanna Tosato
Journal:  Blood       Date:  2006-07-13       Impact factor: 22.113

Review 7.  The EphA2 receptor and ephrinA1 ligand in solid tumors: function and therapeutic targeting.

Authors:  Jill Wykosky; Waldemar Debinski
Journal:  Mol Cancer Res       Date:  2008-12       Impact factor: 5.852

8.  Formation of persistent hyperplastic primary vitreous in ephrin-A5-/- mice.

Authors:  Alexander I Son; Michal Sheleg; Margaret A Cooper; Yuhai Sun; Norman J Kleiman; Renping Zhou
Journal:  Invest Ophthalmol Vis Sci       Date:  2014-03-19       Impact factor: 4.799

9.  Screening for EphB signaling effectors using SILAC with a linear ion trap-orbitrap mass spectrometer.

Authors:  Guoan Zhang; David Fenyö; Thomas A Neubert
Journal:  J Proteome Res       Date:  2008-09-25       Impact factor: 4.466

10.  Identification and functional analysis of phosphorylated tyrosine residues within EphA2 receptor tyrosine kinase.

Authors:  Wei Bin Fang; Dana M Brantley-Sieders; Yoonha Hwang; Amy-Joan L Ham; Jin Chen
Journal:  J Biol Chem       Date:  2008-04-03       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.